Skip to main content
. 2010 Aug 4;10:404. doi: 10.1186/1471-2407-10-404

Table 4.

Neurologic adverse reactions of thalidomide and bortezomib in relation to phenotype in CYP2C19 C and CYP2D6

Parameter CYP2C19
EM
(%)
CYP2C19
IM + PM (%)
P value CYP2D6
UM + EM
(%)
CYP2D6
IM + PM
(%)
p value
Thalidomide
Grade 0 + 1 64 (51) 21 (52) 0.6 NR NR 0.7
Grade 2 36 (29) 5 (13)
Grade 3 26 (21) 14 (35)

Bortezomib
Grade 0 + 1 22 (46) 8 (50) 0.7 14 (54) 8 (42) 0.5
Grade 2 11 (23) 4 (25) 7 (27) 6 (32)
Grade 3 15 (31) 4 (25) 5 (19) 5 (26)

NR: not relevant